US health body questions authenticity of AstraZeneca COVID-19 vaccine trial data
Washington: Results from a US trial of AstraZeneca’s COVID-19 vaccine may have used ‘outdated information’, US federal health officials said ...
Read moreDetailsWashington: Results from a US trial of AstraZeneca’s COVID-19 vaccine may have used ‘outdated information’, US federal health officials said ...
Read moreDetailsLondon: AstraZeneca says advanced trial data from a US study on its COVID vaccine shows it is 79 per cent ...
Read moreDetailsNew Delhi: Following recent concerns raised around blood clots or thrombotic events, AstraZeneca has reassured on the safety of its ...
Read moreDetailsNew York: Even as severe supply constraints remain the biggest concern for many nations trying to accelerate the vaccine drive ...
Read moreDetailsLondon: The Pfizer and Oxford-AstraZeneca COVID-19 vaccines are highly effective in reducing severe coronavirus infection among people aged 70 years ...
Read moreDetailsNew Delhi: A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers. ...
Read moreDetailsNew York: The makers of COVID-19 vaccines are figuring out how to tweak their recipes against worrisome virus mutations. Hence ...
Read moreDetailsGeneva: The World Health Organization (WHO) has decided that potential benefits of the Oxford-AstraZeneca Covid-19 vaccine outweigh known and potential ...
Read moreDetailsLondon: The COVID-19 vaccine developed by Oxford University and produced by AstraZeneca has shown efficacy against the UK variant of ...
Read moreDetailsLondon: The COVID-19 vaccine developed by Oxford University and produced by AstraZeneca has shown efficacy against the UK variant of ...
Read moreDetails